Narayan VM - Search Results

1

Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial.

Narayan VM, Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Mashni J Jr, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Inman BA, Williams MB, Cookson MS, Chang SS, Sankin AI, O'Donnell MA, Sawutz D, Philipson R, Parker NR, Yla-Herttuala S, Rehm D, Jakobsen JS, Juul K, Dinney CPN. Narayan VM, et al. J Urol. 2024 Jul;212(1):74-86. doi: 10.1097/JU.0000000000004020. Epub 2024 May 5. J Urol. 2024. PMID: 38704840 Clinical Trial.

2

Novel biomarkers for prostate cancer: An evidence-based review for use in clinical practice.

Narayan VM, Konety BR, Warlick C. Narayan VM, et al. Int J Urol. 2017 May;24(5):352-360. doi: 10.1111/iju.13326. Epub 2017 Mar 27. Int J Urol. 2017. PMID: 28345187 Review.

3

The Prevalence and Impact of Urinary Marker Testing in Patients with Bladder Cancer.

Narayan VM, Adejoro O, Schwartz I, Ziegelmann M, Elliott S, Konety BR. Narayan VM, et al. J Urol. 2018 Jan;199(1):74-80. doi: 10.1016/j.juro.2017.08.097. Epub 2017 Aug 30. J Urol. 2018. PMID: 28859894

4

The impact of squamous histology on survival in patients with muscle-invasive bladder cancer.

Matulay JT, Woldu SL, Lim A, Narayan VM, Li G, Kamat AM, Anderson CB. Matulay JT, et al. Among authors: narayan vm. Urol Oncol. 2019 Jun;37(6):353.e17-353.e24. doi: 10.1016/j.urolonc.2019.01.020. Epub 2019 Jan 28. Urol Oncol. 2019. PMID: 30704959

5

Clinical and Genomic Considerations for Variant Histology in Bladder Cancer.

Matulay JT, Narayan VM, Kamat AM. Matulay JT, et al. Among authors: narayan vm. Curr Oncol Rep. 2019 Feb 26;21(3):23. doi: 10.1007/s11912-019-0772-8. Curr Oncol Rep. 2019. PMID: 30806832 Review.

6

Re: Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-sparing Trimodality Therapy for Muscle-invasive Bladder Cancer.

Narayan VM, Lim AH, Dinney CPN. Narayan VM, et al. Eur Urol. 2019 Jun;75(6):1034-1035. doi: 10.1016/j.eururo.2019.02.022. Epub 2019 Mar 2. Eur Urol. 2019. PMID: 30833138 No abstract available.

7

Genomic Analysis and Treatment Response of a Bladder Urothelial Carcinoma With Sarcomatoid Variant Histology.

Narayan VM, Gupta S, Davicioni E, Murugan P, Gibb EA, Konety B. Narayan VM, et al. Clin Genitourin Cancer. 2019 Oct;17(5):e888-e892. doi: 10.1016/j.clgc.2019.05.019. Epub 2019 May 25. Clin Genitourin Cancer. 2019. PMID: 31239241 No abstract available.

8

Bacillus Calmette-Guérin Salvage Therapy: Definitions and Context.

Konety BR, Narayan VM, Dinney CPN. Konety BR, et al. Among authors: narayan vm. Urol Clin North Am. 2020 Feb;47(1):1-4. doi: 10.1016/j.ucl.2019.09.002. Urol Clin North Am. 2020. PMID: 31757292 Review.

9

Intravesical Gene Therapy.

Narayan VM, Dinney CPN. Narayan VM, et al. Urol Clin North Am. 2020 Feb;47(1):93-101. doi: 10.1016/j.ucl.2019.09.011. Urol Clin North Am. 2020. PMID: 31757304 Free PMC article. Review.

10

Radical cystectomy in women: Impact of the robot-assisted versus open approach on surgical outcomes.

Narayan VM, Seif MA, Lim AH, Li R, Matulay JT, Kukreja JB, Qiao W, Hwang H, Shah JB, Pisters L, Kamat AM, Dinney C, Navai N. Narayan VM, et al. Urol Oncol. 2020 Apr;38(4):247-254. doi: 10.1016/j.urolonc.2019.12.005. Epub 2020 Jan 14. Urol Oncol. 2020. PMID: 31953001

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters